Kadcyla Drug Interactions: 510 Major, 183 Moderate
Kadcyla (Ado-Trastuzumab Emtansine) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Kadcyla. Always confirm against the full prescribing information.
100 interactions
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Trastuzumab emtansine.
Level 2 evidence
Albendazole
The metabolism of Trastuzumab emtansine can be decreased when combined with Albendazole.
Level 2 evidence
Allopurinol
The risk or severity of adverse effects can be increased when Allopurinol is combined with Trastuzumab emtansine.
Level 1 evidence
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Trastuzumab emtansine.
Level 2 evidence
Apalutamide
The serum concentration of Trastuzumab emtansine can be decreased when it is combined with Apalutamide.
Level 1 evidence
Armodafinil
The metabolism of Trastuzumab emtansine can be increased when combined with Armodafinil.
Level 1 evidence
Articaine
The risk or severity of methemoglobinemia can be increased when Trastuzumab emtansine is combined with Articaine.
Level 1 evidence
Asciminib
The serum concentration of Trastuzumab emtansine can be increased when it is combined with Asciminib.
Level 1 evidence
AstraZeneca COVID-19 Vaccine
The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Trastuzumab emtansine.
Level 2 evidence
Avanafil
The serum concentration of Avanafil can be increased when it is combined with Trastuzumab emtansine.
Level 1 evidence
Azithromycin
The metabolism of Trastuzumab emtansine can be decreased when combined with Azithromycin.
Level 2 evidence
Belantamab mafodotin
The serum concentration of Trastuzumab emtansine can be increased when it is combined with Belantamab mafodotin.
Level 2 evidence
Enter your NPI to unlock 55 major interactions for Kadcyla
Kadcyla (Ado-Trastuzumab Emtansine) has 866 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Kadcyla (Ado-Trastuzumab Emtansine) has 510 major, 183 moderate, and 173 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Kadcyla. Always confirm against the full prescribing information.